Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Grade- Assessed Meta-Analysis of Randomized Controlled Trials

Heart disease remains the world's leading cause of death, claiming millions of lives annually. When the arteries that feed the heart muscle become narrowed or blocked, surgeons often perform a procedure called coronary artery bypass grafting. This operation creates a new path for blood to flow, bypassing the blockage to restore life-giving oxygen to the heart. To build these new paths, surgeons need a conduit, a tube to carry the blood. The two most common materials used for this job are a vein taken from the patient's leg and an artery taken from the patient's forearm. For decades, the medical community has debated which of these two options is better for the long-term health of the patient. One is a vein, which is naturally designed to carry blood at low pressure, while the other is an artery, built to handle the high-pressure surge of blood pumped directly from the heart. Choosing the right material is critical because the longevity of the bypass depends heavily on how well the graft survives inside the body over many years.

A recent systematic review and meta-analysis set out to settle this debate by gathering data from the highest quality studies available: randomized controlled trials. In these trials, patients are randomly assigned to receive either the radial artery from the arm or the saphenous vein from the leg, ensuring that the comparison is fair and free from bias. The researchers analyzed four such trials involving nearly 1,200 grafts to see which material held up better over time. They looked specifically at whether the grafts failed, meaning they became blocked, and they distinguished between two types of blockage. One type is a complete physical clog where the tube is entirely shut. The other is a functional issue where the tube remains open but narrows significantly because the blood flow conditions around it cause it to spasm or shrink, a phenomenon known as the "string sign."

The study found that neither graft is universally superior for every patient. When looking at the overall rate of graft failure, the difference between the two materials was not statistically significant. The radial artery grafts failed in about 12 percent of cases, while the vein grafts failed in about 15 percent. While the artery grafts performed slightly better on paper, the data was not strong enough to declare a clear winner across the board. However, when the researchers looked deeper into the specific ways the grafts failed, a clearer picture emerged. The radial artery grafts were significantly less likely to suffer from a complete, physical blockage. In contrast, the vein grafts were more prone to closing up entirely. This suggests that the artery material is more durable against total collapse.

Yet, the story is not entirely one-sided. The radial artery grafts showed a much higher tendency to develop the "string sign," a functional narrowing where the graft remains open but becomes very thin and weak. This happened in about 6 percent of the artery grafts compared to less than 1 percent of the vein grafts. This narrowing often occurs when the native artery it is connected to is not blocked enough to force blood through the new graft, causing the graft to spasm and shrink in response to the low demand. This functional issue is different from a permanent clog; it is a reaction to the local blood flow environment. The researchers noted that this specific finding was heavily influenced by one particular study in the group, and when that study was set aside, the difference in functional narrowing became less certain. This highlights that the results are sensitive to the specific data included and that the behavior of these grafts can vary depending on the patient's unique anatomy.

The analysis also examined the most serious outcomes for patients: death and the need for repeat surgery. The study found no significant difference in the rates of death between the two groups, nor was there a clear difference in how often patients needed a second procedure to fix a failing graft. The researchers concluded that while the radial artery may offer better protection against total blockage, its susceptibility to functional narrowing means it is not a perfect solution for everyone. The choice of graft should not be a one-size-fits-all decision but rather an individualized one based on the patient's specific characteristics and the condition of their heart vessels. The evidence suggests that both options are clinically acceptable, and the best choice depends on matching the right conduit to the right patient to ensure the heart receives the blood it needs for the long term.